Related Experiment Videos

Correction: Efficacy and safety of camrelizumab plus apatinib for solid tumors: a meta-analysis

Ping Yu1, Xiaoyu Song1,2, Yue Li1

  • 1Department of Pharmacy, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

Frontiers in Immunology
|October 13, 2026
PubMed